drugset / Trial / NCT01010152
Comparative Bioavailability Study of Codeine Sulfate
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study was to assess the comparative bioavailability of codeine from Roxane Laboratories' Codeine Sulfate 30mg tablets to Tylenol® #3 (acetaminophen 300mg with codeine phosphate 30mg) under fasted conditions
Timeline
- Start
- 2008-01
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Codeine | Small molecule | 30 mg | — |
Indications
No indication recorded.